News
Global Health Innovative Technology (GHIT) Fund has awarded a two-year, approximately $4.5 million grant to Fujirebio’s wholly-owned subsidiary, Fluxus, Inc. (Location: Sunnyvale, California), to ...
1h
News-Medical.Net on MSNUC3M unveils three scientific research projects to combat tuberculosisUniversidad Carlos III de Madrid (UC3M) has presented three scientific research projects contributing to the fight against ...
Children on higher-dose tuberculosis treatment regimens, as per 2010 World Health Organization guidelines, experience more ...
After an investigation from the Canadian Food Inspection Agency (CFIA) began in December, it’s been determined that a farm in ...
Paraguay’s Health Ministry and the Pan American Health Organization (PAHO) have launched a joint technical mission to ...
7hon MSN
Many European countries are off track to meet official goals on HIV, TB, hepatitis, and STIs, a new report shows. View on ...
The hotel is planning a renovation of the historic Marian Hall, creating about 40 additional rooms annexed onto its existing ...
An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, investigators ...
The 25% reduction in the price of pretomanid could save Global Drug Facility clients upwards of $3 million a year.
China's success in achieving malaria-free status in 2021 offers crucial lessons for the global malaria fight, say experts in ...
Tuberculosis (TB) is an infectious disease that kills more than a million people worldwide every year. The pathogen that causes the disease, Mycobacterium tuberculosis, is deadly in part because of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results